1. Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review

   • Stavroula A. Paschou
   • Kleoniki I. Athanasiadou
   • Nikolaos Papanas

   Review Open access 16 February 2024 Pages: 741 - 748

2. Personalized Versus Non-personalized Nutritional Recommendations/Interventions for Type 2 Diabetes Mellitus Remission: A Narrative Review

   • Ana T. Arias-Marroquín
   • Fabiola M. Del Razo-Olvera
   • Carlos A. Aguilar-Salinas

   Review Open access 20 February 2024 Pages: 749 - 761

   

3. Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

   • Hiroaki Iijima
   • Hidetoshi Shimizu
   • Takashi Kadowaki

   Original Research Open access 20 December 2023 Pages: 763 - 777

   

4. Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

   • Hiroaki Iijima
   • Hidetoshi Shimizu
   • Takashi Kadowaki

   Publisher Correction Open access 29 February 2024 Pages: 779 - 780

5. Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

   • Yuying Cui
   • Jinming Yao
   • Lin Liao

   Original Research Open access 24 February 2024 Pages: 781 - 799

   

6. Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study

   • Kazuo Hara
   • Tetsuaki Hirase
   • Ryo Takemura

   Original Research Open access 24 February 2024 Pages: 801 - 817

   

7. Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

   • Xiaosu Ma
   • Rong Liu
   • Kyle W. Sloop

   Original Research Open access 24 February 2024 Pages: 819 - 832

   

8. Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis

   • Jonathan Y. M. Lai
   • David R. Riley
   • Uazman Alam

   Original Research Open access 24 February 2024 Pages: 833 - 842

   

9. Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study

   • Amy L. McKenzie
   • Shaminie J. Athinarayanan

   Original Research Open access 29 February 2024 Pages: 843 - 853

   

10. Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

    • Meredith Hoog
    • Juan M. Maldonado
    • Manige Konig

    Original Research Open access 01 March 2024 Pages: 855 - 867

    

11. Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study

    • Sharmistha Roy Chowdhury
    • Fethi Sadouki
    • Stephen C. Bain

    Brief Report Open access 01 March 2024 Pages: 869 - 881

    

12. Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan

    • Junko Sato
    • Kenichi Nakajima
    • Hirotaka Watada

    Study Protocol Open access 15 February 2024 Pages: 883 - 892